Capabilities Built for Translational Evidence.
ImageNova Bioscience supports precision oncology and radiopharmaceutical development through integrated capabilities in target discovery, probe synthesis, radiolabeling, in vitro evaluation, tumor models, and in vivo molecular imaging.
From molecular design to in vivo validation.
AI-Driven Target Discovery
Integrating biological data and literature intelligence to validate disease-relevant targets for precision oncology programs.
Probe Synthesis & Radiolabeling
Advanced chemistry for PET/CT probes and radiopharmaceuticals, evaluating tumor uptake, biodistribution, and target engagement.
In Vitro Evaluation
De-risking candidates through binding, specificity, and stability assays before progressing to in vivo molecular imaging studies.
Tumor Models
Scientifically credible models designed for molecular imaging, radiopharmaceutical testing, and therapeutic response assessment.
Molecular Imaging Validation
Visualizing and quantifying drug kinetics, PK/PD, and safety signals in living systems to reveal complex molecular biology.
Translational Decision Support
Integrated analysis and data interpretation to drive study plans aligned with precision oncology and scientific goals.
Start with the right target.
We support target discovery and validation for precision oncology programs by integrating biological data, literature intelligence, disease relevance, and translational feasibility.
Build probes designed to reveal biology.
ImageNova supports probe synthesis and radiolabeling for imaging and radiopharmaceutical research, enabling evaluation of tumor uptake, biodistribution, target engagement, and therapeutic potential.
De-risk before moving in vivo.
Before animal studies, candidates can be evaluated for binding, specificity, stability, uptake, retention, and functional performance through tailored in vitro workflows.
Models that bring biology closer to the patient.
ImageNova supports preclinical oncology studies using tumor models designed for molecular imaging, radiopharmaceutical testing, biodistribution analysis, and therapeutic response assessment.
See what the molecule does inside the body.
Our molecular imaging capabilities help visualize and quantify biodistribution, pharmacokinetics, target engagement, tumor uptake, therapeutic response, and safety signals in living systems.
Bring your candidate from concept to evidence.
Tell us about your target, probe, or therapeutic program. We’ll help design a study plan aligned with your scientific and translational goals.